X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-06-16 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $58.11 | -4,750 | 69,075 | -6% | -$276,023 | ||||||
2026-06-16 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $20.71 | -8,587 | 127,711 | -6% | -$177,837 | ||||||
2026-06-16 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $216.78 | -2,964 | 3,124 | -49% | -$642,536 | ||||||
2026-06-15 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $211.14 | -3,150 | 288,416 | -1% | -$665,087 | ||||||
2026-06-15 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | See Remarks | S - Sale | $101.47 | -2,832 | 34,968 | -7% | -$287,363 | ||||||
| D | 2026-06-15 | BLLN | Billiontoone, Inc. | Tsao David | CTO | S - Sale+OE | $102.27 | -20,000 | 1,000 | -95% | -$2,045,326 | |||||
| D | 2026-06-15 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $20.66 | -4,172 | 253,861 | -2% | -$86,194 | |||||
2026-06-15 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $24.03 | -17,683 | 631,959 | -3% | -$424,877 | ||||||
| M | 2026-06-12 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $214.47 | -100,000 | 2,282,843 | -4% | -$21,447,308 | |||||
2026-06-15 | CDNA | Caredx, Inc. | Valantine Hannah | Dir | S - Sale | $23.11 | -12,103 | 36,686 | -25% | -$279,728 | ||||||
| D | 2026-06-16 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $130.19 | -116 | 8,796 | -1% | -$15,102 | |||||
2026-06-15 | RDNT | Radnet, Inc. | Forthuber Stephen M | Pres, CEO-Eastern Operations | S - Sale | $58.16 | -44,067 | 507,199 | -8% | -$2,562,911 | ||||||
2026-06-11 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $130.24 | -3,418 | 41,090 | -8% | -$445,156 | ||||||
2026-06-11 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $24.02 | -21,998 | 649,642 | -3% | -$528,443 | ||||||
2026-06-11 | SERA | Sera Prognostics, Inc. | Anderson Dyaarl Lee Jr. | Chief Commercial Officer | S - Sale | $2.01 | -4,739 | 77,998 | -6% | -$9,525 | ||||||
2026-06-11 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.01 | -2,037 | 301,190 | -1% | -$4,094 | ||||||
2026-06-11 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.01 | -6,990 | 865,009 | -1% | -$14,050 | ||||||
2026-06-11 | SERA | Sera Prognostics, Inc. | Inglis Tiffany Eul Davis | Chief Medical Officer | S - Sale | $2.01 | -362 | 92,075 | 0% | -$728 | ||||||
2026-06-11 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.01 | -2,179 | 161,756 | -1% | -$4,380 | ||||||
2026-06-10 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $130.41 | -5,000 | 44,508 | -10% | -$652,030 | ||||||
2026-06-10 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale | $16.82 | -4,674 | 75,990 | -6% | -$78,617 | ||||||
2026-06-08 | BLLN | Billiontoone, Inc. | Sakakibara Shan Riku | Chief Product Officer | S - Sale | $98.23 | -8,000 | 212,000 | -4% | -$785,800 | ||||||
| M | 2026-06-08 | BLLN | Billiontoone, Inc. | Johnson Nancy Joann | See Remarks | S - Sale | $100.18 | -14,000 | 21,900 | -39% | -$1,402,540 | |||||
| D | 2026-06-08 | BLLN | Billiontoone, Inc. | Atay Oguzhan | See Remarks | S - Sale+OE | $97.84 | -38,750 | 187,500 | -17% | -$3,791,445 | |||||
2026-06-09 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.08 | -20,755 | 871,999 | -2% | -$43,170 | ||||||
2026-06-09 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.08 | -5,440 | 303,227 | -2% | -$11,315 | ||||||
2026-06-08 | LH | Labcorp Holdings Inc. | Kyle Kathryn W | EVP, GC | S - Sale | $263.89 | -762 | 3,813 | -17% | -$201,084 | ||||||
| D | 2026-06-05 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $217.21 | -11,000 | 6,183 | -64% | -$2,389,328 | |||||
2026-06-08 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $2.15 | -1,560 | 16,473 | -9% | -$3,354 | ||||||
2026-06-05 | GH | Guardant Health, Inc. | Eltoukhy Helmy | Co-CEO | S - Sale | $126.30 | -100,000 | 2,012,919 | -5% | -$12,629,969 | ||||||
2026-06-05 | GH | Guardant Health, Inc. | Bell Michael Brian | CFO | S - Sale | $128.62 | -2,000 | 47,509 | -4% | -$257,241 | ||||||
| D | 2026-06-04 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale+OE | $200.00 | -8,147 | 15,589 | -34% | -$1,629,400 | |||||
2026-06-04 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $24.00 | -4,835 | 671,640 | -1% | -$116,045 | ||||||
2026-06-04 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $221.03 | -41,124 | 108,743 | -27% | -$9,089,776 | ||||||
| D | 2026-06-04 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $12.01 | -40,000 | 198,833 | -17% | -$480,400 | |||||
2026-06-04 | GRAL | Grail, Inc. | Partridge Andrew John | Chief Growth Officer | S - Sale | $61.08 | -1,491 | 163,738 | -1% | -$91,070 | ||||||
2026-06-04 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | S - Sale | $132.51 | -9,294 | 10,222 | -48% | -$1,231,522 | ||||||
2026-06-04 | VCYT | Veracyte, Inc. | McGuire Annie | EVP, GC | S - Sale | $49.76 | -3,176 | 137,240 | -2% | -$158,036 | ||||||
2026-06-04 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $49.73 | -3,561 | 173,280 | -2% | -$177,083 | ||||||
| D | 2026-06-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale+OE | $50.12 | -138,051 | 440,494 | -24% | -$6,919,585 | |||||
2026-06-04 | VCYT | Veracyte, Inc. | Leite John | Global Chief Commercial Off | S - Sale | $50.07 | -13,975 | 132,305 | -10% | -$699,732 | ||||||
| D | 2026-06-03 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $126.98 | -10,000 | 11,183 | -47% | -$1,269,809 | |||||
2026-06-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $218.43 | -3,000 | 137,643 | -2% | -$655,295 | ||||||
2026-06-02 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $17.89 | -2,146 | 588,421 | 0% | -$38,382 | ||||||
2026-06-02 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $17.89 | -1,688 | 990,374 | 0% | -$30,191 | ||||||
2026-06-01 | NTRA | Natera, Inc. | Botha Roelof | Dir | S - Sale | $220.31 | -78,000 | 1,079,092 | -7% | -$17,184,092 | ||||||
| D | 2026-06-01 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $20.86 | -9,836 | 257,483 | -4% | -$205,149 | |||||
| D | 2026-06-02 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $15.49 | -4,866 | 80,664 | -6% | -$75,374 | |||||
| D | 2026-06-02 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $15.49 | -4,866 | 78,416 | -6% | -$75,374 | |||||
2026-06-01 | DGX | Quest Diagnostics Inc | Davis J. E. | CEO, Pres | S - Sale | $194.14 | -10,000 | 132,423 | -7% | -$1,941,400 | ||||||
| DM | 2026-05-28 | PSNL | Personalis, Inc. | Hall Christopher M | CEO | S - Sale+OE | $11.02 | -100,000 | 235,986 | -30% | -$1,102,000 | |||||
| D | 2026-05-29 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $11.58 | -38,799 | 198,833 | -16% | -$449,292 | |||||
2026-05-28 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale | $130.06 | -1,000 | 639 | -61% | -$130,060 | ||||||
2026-05-26 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $202.84 | -1,652 | 140,643 | -1% | -$335,091 | ||||||
2026-05-26 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $202.84 | -1,438 | 185,782 | -1% | -$291,684 | ||||||
2026-05-27 | GH | Guardant Health, Inc. | Saia John G. | GC | S - Sale | $125.08 | -10,000 | 35,950 | -22% | -$1,250,836 | ||||||
2026-05-27 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $17.60 | -1,201 | 590,567 | 0% | -$21,138 | ||||||
2026-05-27 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $17.60 | -945 | 992,062 | 0% | -$16,632 | ||||||
| D | 2026-05-22 | VCYT | Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | S - Sale+OE | $45.40 | -24,000 | 45,434 | -35% | -$1,089,624 | |||||
| D | 2026-05-22 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale+OE | $118.67 | -24,406 | 60,034 | -29% | -$2,896,360 | |||||
2026-05-20 | GH | Guardant Health, Inc. | Saia John G. | GC | S - Sale | $106.51 | -20,000 | 45,950 | -30% | -$2,130,229 | ||||||
2026-05-20 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $109.89 | -210,000 | 1,886,504 | -10% | -$23,076,690 | ||||||
2026-05-20 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale | $106.90 | -6,876 | 2,975 | -70% | -$735,049 | ||||||
| D | 2026-05-20 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale+OE | $107.09 | -1,250 | 1,639 | -43% | -$133,864 | |||||
2026-05-20 | VCYT | Veracyte, Inc. | Epstein Robert S | Dir | S - Sale | $44.01 | -10,000 | 52,446 | -16% | -$440,129 | ||||||
| DM | 2026-05-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $20.15 | -4,172 | 261,105 | -2% | -$84,066 | |||||
2026-05-19 | LMRI | Lumexa Imaging Holdings, Inc. | Brodnax Brett | Dir | P - Purchase | $7.25 | +35,000 | 62,027 | +130% | +$253,750 | ||||||
2026-05-18 | FTRE | Fortrea Holdings Inc. | Parks Robert | Chief Accounting Officer | S - Sale | $13.44 | -2,000 | 20,389 | -9% | -$26,880 | ||||||
| D | 2026-05-18 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $95.96 | -116 | 8,662 | -1% | -$11,131 | |||||
2026-05-14 | LMRI | Lumexa Imaging Holdings, Inc. | Cooper Henry Lee | Dir | P - Purchase | $7.44 | +30,000 | 30,000 | New | +$223,113 | ||||||
| M | 2026-05-14 | CDNA | Caredx, Inc. | Torres Arthur A | Dir | S - Sale | $20.31 | -10,570 | 38,665 | -21% | -$214,676 | |||||
| M | 2026-05-08 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $206.33 | -4,650 | 291,566 | -2% | -$959,451 | |||||
2026-05-12 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $100.32 | -50,000 | 2,096,504 | -2% | -$5,016,000 | ||||||
2026-05-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $254.50 | -5,903 | 107,234 | -5% | -$1,502,314 | ||||||
2026-05-12 | ACON | Aclarion, Inc. | Breidbart Scott | Dir | P - Purchase | $3.18 | +5,664 | 5,664 | New | +$18,012 | ||||||
2026-05-11 | ACON | Aclarion, Inc. | Neal David K | Dir | P - Purchase | $3.10 | +2,500 | 2,502 | >999% | +$7,750 | ||||||
2026-05-11 | CAI | Caris Life Sciences, Inc. | Vacirca Jeff L | Dir | P - Purchase | $16.15 | +31,050 | 49,671 | +167% | +$501,426 | ||||||
2026-05-11 | ACON | Aclarion, Inc. | Ness Brent | CEO | P - Purchase | $3.18 | +6,289 | 6,300 | >999% | +$19,999 | ||||||
| D | 2026-05-07 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $22.15 | -9,836 | 264,727 | -4% | -$217,904 | |||||
2026-05-06 | ACON | Aclarion, Inc. | Wesemann William | Dir | P - Purchase | $3.30 | +1,562 | 1,563 | >999% | +$5,155 | ||||||
2026-05-06 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $39.03 | -10,204 | 143,708 | -7% | -$398,211 | ||||||
| M | 2026-05-04 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $213.05 | -7,708 | 2,382,843 | 0% | -$1,642,211 | |||||
2026-05-04 | CELC | Celcuity Inc. | Dalvey David | Dir | S - Sale | $140.68 | -25,000 | 65,000 | -28% | -$3,517,000 | ||||||
| D | 2026-05-04 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $140.47 | -9,000 | 7,789 | -54% | -$1,264,181 | |||||
2026-05-05 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $20.68 | -2,688 | 113,924 | -2% | -$55,581 | ||||||
| M | 2026-05-01 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $208.79 | -795 | 57,496 | -1% | -$165,984 | |||||
2026-05-01 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $206.16 | -107 | 296,216 | 0% | -$22,059 | ||||||
2026-05-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $203.69 | -3,405 | 142,295 | -2% | -$693,560 | ||||||
2026-05-01 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $206.16 | -291 | 187,220 | 0% | -$59,993 | ||||||
2026-05-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $206.16 | -902 | 149,867 | -1% | -$185,956 | ||||||
2026-05-01 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $206.16 | -330 | 222,694 | 0% | -$68,033 | ||||||
| M | 2026-04-20 | LUDG | Ludwig Enterprises, Inc. | Hausman Marvin S Md | 10% | S - Sale | $0.02 | -2,000,000 | 37,758,000 | -5% | -$40,000 | |||||
| M | 2026-04-27 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $197.84 | -5,063 | 58,291 | -8% | -$1,001,645 | |||||
2026-04-27 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $204.14 | -5,838 | 150,769 | -4% | -$1,191,775 | ||||||
2026-04-27 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $204.10 | -1,688 | 187,511 | -1% | -$344,517 | ||||||
2026-04-27 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $204.10 | -2,182 | 145,700 | -1% | -$445,341 | ||||||
2026-04-27 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $204.09 | -1,861 | 223,024 | -1% | -$379,811 | ||||||
| M | 2026-04-27 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $197.43 | -3,544 | 296,275 | -1% | -$699,693 | |||||
| D | 2026-04-21 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $25.10 | -4,172 | 268,349 | -2% | -$104,709 | |||||
2026-04-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $199.63 | -1,500 | 299,819 | 0% | -$299,441 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |